[1. Bulgarian national cancer registry. [Cancer incidence in Bulgaria - data for 2010]. [Internet] 2018 [cited 2018 Nov 27]. Available from: http://www.sbaloncology.bg/en/ncr.html. Bulgarian.]Search in Google Scholar
[2. National Human Genome Research Institute. Breast cancer information core [Internet] 2017 [cited 2018 Oct 14]. Available from: http://research.nhgri.nih.gov/projects/bic/]Search in Google Scholar
[3. Peto J, Collins N, Barfoot R, Seal S, Warren W, Rahman N, et al. Prevalence of BRCA1 and BRCA2 gene mutations in patients with early-onset breast cancer. J Natl Cancer Inst. 1999;91(11):943-9.10.1093/jnci/91.11.94310359546]Search in Google Scholar
[4. Serova OM, Mazoyer S, Puget N, Dubois V, Tonin P, Shugart YY, et al. Mutations in BRCA1 and BRCA2 in breast cancer families: are there more breast cancer-susceptibility genes? Am J Hum Genet. 1997;60(3):486-95.]Search in Google Scholar
[5. Neuhausen SL. Founder populations and their uses for breast cancer genetics. Breast Cancer Res. 2000;2(2):77-81.10.1186/bcr3613942611250694]Search in Google Scholar
[6. Phelan CM, Kwan E, Jack E, Li S, Morgan C, Aubé J, et al. A low frequency of non-founder BRCA1 mutations in Ashkenazi Jewish breast-ovarian cancer families. Hum Mutat. 2002;20(5):352-7.10.1002/humu.1012312402332]Search in Google Scholar
[7. Górski B, Jakubowska A, Huzarski T, Byrski T, Gronwald J, Grzybowska E, et al. A high proportion of founder BRCA1 mutations in Polish breast cancer families. Int J Cancer 2004;110(5):683-6.10.1002/ijc.2016215146557]Search in Google Scholar
[8. Dodova RI, Mitkova AV, Dacheva DR, Hadjo LB, Vlahova AI, Hadjieva MST, et al. Spectrum and frequencies of BRCA1/2 mutations in Bulgarian high risk breast cancer patients. BMC Cancer. 2015 Jul.10.1186/s12885-015-1516-2450406626183948]Search in Google Scholar
[9. National Human Genome Research Institute. Breast cancer information core [Internet] 2017. [cited 2018 Oct 14]. Available from: http://research.nhgri.nih.gov/projects/bic/Member/brca1mutationdatabase.shtml.]Search in Google Scholar
[10. Fackenthal JD, Olopade OI: Breast cancer risk associated with BRCA1 and BRCA2 in diverse populations. Nat Rev Cancer. 2007;7(12):937-48.10.1038/nrc205418034184]Search in Google Scholar
[11. Gaj P, Kluska A, Nowakowska D, Balabas A, Piatkowska M, Dabrowska M, et al. High frequency of BRCA1 founder mutations in Polish women with nonfamilial breast cancer. Fam Cancer. 2012;11(4):623-8.10.1007/s10689-012-9560-422864640]Search in Google Scholar
[12. Møller P, Hagen AI, Apold J, Maehle L, Clark N, Fiane B, et al. Genetic epidemiology of BRCA mutations - family history detects less than 50% of the mutation carriers. Eur J Cancer. 2007;43(11):1713-7.10.1016/j.ejca.2007.04.02317574839]Search in Google Scholar
[13. De Leeneer K, Coene I, Crombez B, Simkens J, Van den Broecke R, Bols A, et al. Prevalence of BRCA1/2 mutations in sporadic breast/ovarian cancer patients and identification of a novel de novo BRCA1 mutation in a patient diagnosed with late onset breast and ovarian cancer: implications for genetic testing. Breast Cancer Res Treat. 2012;132(1):87-95.10.1007/s10549-011-1544-921553119]Search in Google Scholar
[14. Hartman AR, Kaldate RR, Sailer LM, Painter L, Grier CE, Endsley RR, et al. Prevalence of BRCA mutations in an unselected population of triple-negative breast cancer. Cancer. 2012;118(11):2787-95.10.1002/cncr.2657622614657]Search in Google Scholar
[15. Hamel N, Feng BJ, Foretova L, Stoppa-Lyonnet D, Narod SA, Imyanitov E et al. On the origin and diffusion of BRCA1 c.5266dupC (5382insC) in European populations. Eur J Hum Genet. 2011;19(3):300-6.10.1038/ejhg.2010.203]Search in Google Scholar
[16. Sokolenko AP, Mitiushkina NV, Buslov KG, Bit-Sava EM, Iyevleva AG, Chekmariova EV, et al. High frequency of BRCA1 5382insC mutation in Russian breast cancer patients. Eur J Cancer. 2006;42(10):1380-4.10.1016/j.ejca.2006.01.050]Search in Google Scholar
[17. Ramus SJ, Kote-Jarai Z, Friedman LS, van der Looij M, Gayther SA, Csokay B, et al. Analysis of BRCA1 and BRCA2 mutations in Hungarian families with breast or breast-ovarian cancer. Am J Hum Genet. 1997;60(5):1242-6.]Search in Google Scholar
[18. Krajc M, Teugels E, Zgajnar J, Goelen G, Besic N, Novakovic S, et al. Five recurrent BRCA1/2 mutations are responsible for cancer predisposition in the majority of Slovenian breast cancer families. BMC Med Genet. 2008;9:83.10.1186/1471-2350-9-83]Search in Google Scholar
[19. Couch FJ, Weber BL. Mutations and polymorphisms in the familial early-onset breast cancer (BRCA1) gene. Breast Cancer Information Core. Hum Mutat. 1996;8(1):8-18.10.1002/humu.1380080102]Search in Google Scholar
[20. Ladopoulou A, Kroupis C, Konstantopoulou I, Ioannidou-Mouzaka L, Schofield AC, Pantazidis A, et al. Germ line BRCA1 & BRCA2 mutations in Greek breast/ovarian cancer families: 5382insC is the most frequent mutation observed. Cancer Lett. 2002;185(1):61-70.10.1016/S0304-3835(01)00845-X]Search in Google Scholar
[21. Backe J, Hofferbert S, Skawran B, Dork T, Stuhrmann M, Karstens JH, et al. Frequency of BRCA1 mutation 5382insC in German breast cancer patients. Gynecol Oncol. 1999;72(3):402-6.10.1006/gyno.1998.527010053113]Search in Google Scholar
[22. Caligo MA, Ghimenti C, Cipollini G, Ricci S, Brunetti I, Marchetti V, et al. BRCA1 germline mutational spectrum in Italian families from Tuscany: a high frequency of novel mutations. Oncogene. 1996;13(7):1483-8.10.1016/S0165-4608(97)82515-0]Search in Google Scholar
[23. Ferla R, Calò V, Cascio S, Rinaldi G, Badalamenti G, Carreca I et al. Founder mutations in BRCA1 and BRCA2 genes. Ann Oncol. 2007;18 Suppl 6:vi93-8.10.1093/annonc/mdm23417591843]Search in Google Scholar